skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Your thoughts on Skylight Health Group please.Thanks.
Read Answer Asked by maurice on December 14, 2020
Q: ABNB,

Do you have any thoughts on strength of the recent IPO?
Jim Crammer, benefiting from 20/20 hindsight, comments that he felt that the IPO was under-priced.

For someone interested in playing covid recovery 2021 theme, do you see 5i including ABNB in the groups of US equities currently referenced as potential benefactors. ie Wynn, LUV, BKNG

Cheers!
Read Answer Asked by Duane on December 14, 2020
Q: Hi - huge pop on the IPO for AbCellera. Sounds promising, what would your take be on investing in it now? Better to wait for some of the enthusiasm to die down? Looks like it has a strong US following.
Read Answer Asked by Jason on December 14, 2020
Q: Trades as SONG In London and HPGSF on TD Ameritrade. A royalty fund with many institutional investors? Your views?
Read Answer Asked by William Ross on December 14, 2020
Q: Hello 5i Team
Now that Sandpiper has reorganized the board of ARTIS, will appoint a new CEO effective January 01, 2020 and will proceed with their 100 day plan, I have the following questions:
1 – Is ARTIS REIT at the current price $10.89 a reasonable price to pay, provided ARTIS/Sandpiper can complete their 100 day plan and hopefully realize Sandpiper’s estimated NAV at $15.40?
2 – Are any of the three outstanding ARTIS preferred units (AX-PR-A, AX-PR-E and AX-PR-I) a better way to play this story?
3 – Any thoughts on other Canadian REITS that could be put into play by activist investors, given most of the undervalued REITs are majority controlled by the parent corporation (Melcor REIT, Morguard REIT etc.).
Thanks
Read Answer Asked by Stephen on December 14, 2020
Q: what is the forecast EPS for 2021 for xbc well and real? if losses are projected has management forecast a future date when their respective companies might achieve profitably? thanks Richard
Read Answer Asked by richard on December 14, 2020
Q: Hi

The Globe and Mail mentioned potential Cloud investment ideas today. CLOU-Q, WCLD-Q, SKYY and a new Canadian name DATA-T. I currently own Microsoft which gives me some Cloud exposure. I am wondering what your opinion would be to invest in this space?

Kim
Read Answer Asked by kim on December 14, 2020
Q: Can you comment on any recent insider buying or selling for GUD. E.g. has the CEO bought any large chunks? I am curious if there has been some insider purchasing/selling either before or after the shelf filing. If there has been buying, what do you think are the odds that there might be an acquisition in the works. I bought GUD at $5 and am trying to decide whether to hold, sell, or top up. Because everything else in my portfolio has done so well this year (all fantastic 5i suggestions), GUD has decreased to 1.3% of total holdings.
Read Answer Asked by Justin on December 14, 2020
Q: I recently purchased Qualcomm as it seems to be a frequent recommendation of 5i's.
I'm around the break even point at this time due to its decline on Friday after news came out about Apple making its own chips, replacing those of Qualcomm.
This represents about 11% of their revenue.
Do you still recommend holding the stock or switch to something like Nvidia?
Read Answer Asked by Bruce on December 14, 2020
Q: I am looking at reducing the number of holdings that I currently have. Please rate the sell order you would have for the above companies
Read Answer Asked by James on December 14, 2020
Q: I plan on adding to the following positions within my TFSA. What would be your order of buying?
Read Answer Asked by James on December 14, 2020
Q: Hi guys. Would you be able to tell me your ratings on these medical stocks for growth and risk please. It would be a 3 year time frame minimum. Thks again for the great job you do.
Read Answer Asked by wilson on December 14, 2020
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!